These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11480698)
21. [Psychiatrists and the pharmaceutical industry]. Helmchen H Nervenarzt; 2003 Nov; 74(11):955-64. PubMed ID: 14694885 [TBL] [Abstract][Full Text] [Related]
22. On bias and transparency in the development of influential recommendations. Laupacis A CMAJ; 2006 Jan; 174(3):335-6. PubMed ID: 16446476 [No Abstract] [Full Text] [Related]
23. Gifts from the pharmaceutical industry. Jorm AF Med J Aust; 1997 Apr; 166(7):386-7. PubMed ID: 9137287 [No Abstract] [Full Text] [Related]
25. Pharmaceutical sales strategies and sponsorship. Sturgiss EA; Douglas K; Trumble SC Med J Aust; 2015 Feb; 202(3):131. PubMed ID: 25669470 [No Abstract] [Full Text] [Related]
26. The reputation of nurses: the good and the bad, but what about the truth? Hooper VD J Perianesth Nurs; 2001 Apr; 16(2):145-6. PubMed ID: 11290997 [No Abstract] [Full Text] [Related]
27. Relationships Between Academic Medicine Leaders and Industry-Time for Another Look? Becker C JAMA; 2020 Nov; 324(18):1833-1834. PubMed ID: 33170245 [No Abstract] [Full Text] [Related]
28. Professional organizations and healthcare industry support: ethical conflict? Hazlet TK; Sullivan SD Camb Q Healthc Ethics; 1994; 3(2):236-44; discussion 244-56. PubMed ID: 8049771 [No Abstract] [Full Text] [Related]
29. Ethics and drugs. Goldberg A Ir J Med Sci; 1990 Aug; 159(8):242-3. PubMed ID: 2076946 [No Abstract] [Full Text] [Related]
30. Lessons on ethical decision making from the bioscience industry. Mackie JE; Taylor AD; Finegold DL; Daar AS; Singer PA PLoS Med; 2006 May; 3(5):e129. PubMed ID: 16573361 [TBL] [Abstract][Full Text] [Related]
31. Collaborating with industry--choices for the academic medical center. Moses H; Braunwald E; Martin JB; Thier SO N Engl J Med; 2002 Oct; 347(17):1371-5. PubMed ID: 12397200 [No Abstract] [Full Text] [Related]
32. Academic medicine and industry--the ethical dilemma. Sarmiento A Iowa Orthop J; 2000; 20():87-90. PubMed ID: 10934631 [No Abstract] [Full Text] [Related]
33. Transparency and trust. Compston JE Osteoporos Int; 2010 May; 21(5):711-2. PubMed ID: 20238100 [No Abstract] [Full Text] [Related]
34. Institutional conflict of interest. Emanuel EJ; Steiner D N Engl J Med; 1995 Jan; 332(4):262-7. PubMed ID: 7808495 [No Abstract] [Full Text] [Related]
35. Drug advertising: truths, half-truths and few statistics. Newby DA; Henry DA Med J Aust; 2002 Sep; 177(6):285-6. PubMed ID: 12225271 [No Abstract] [Full Text] [Related]
36. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey. Ball DE; Tisocki K; Herxheimer A BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025 [TBL] [Abstract][Full Text] [Related]
37. Disease management. What happened to the unlikely lads. O'Connell N Health Serv J; 2000 May; 110(5706):suppl 6, 8. PubMed ID: 11183792 [No Abstract] [Full Text] [Related]
38. The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest. Allman RL HEC Forum; 2003 Jun; 15(2):155-70. PubMed ID: 12918283 [No Abstract] [Full Text] [Related]
39. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
40. Relations between health professionals and industry: conflicts of interest. Prescrire Int; 2000 Aug; 9(48):126. PubMed ID: 11067728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]